Petitioner: DEPARTMENT OF HEALTH, BOARD OF MEDICINE
Respondent: DOUGLAS SMITH, M.D.
Judges: LARRY J. SARTIN
Agency: Department of Health
Locations: West Palm Beach, Florida
Filed: Sep. 18, 2009
Status: Closed
Settled and/or Dismissed prior to entry of RO/FO on Wednesday, November 4, 2009.
Latest Update: Feb. 22, 2025
Sep 18 2009 14:2
Sep 18 2009 14:16 P03
qi Lb
!
STATE OF FLORIDA
DEPARTMENT OF HEALTH
DEPARTMENT OF HEALTH,
PETITIONER,
CASE NO. 2006-28876
Vv.
DOUGLAS SMITH, M.D.
RESPONDENT.
ee
ADMINISTRATIVE COMPLAINT
COMES NOW, Petitioner, Department of Health, by and through its
undersigned counsel, and files this Administrative Complaint before the
Board of Medicine against Respondent, Douglas Smith, M.D., and in
support thereof alleges: |
Petitioner is the state department charged with regulating the
1.
practice of medicine pursuant to Section 20.43, Florida Statutes; Chapter
456, Florida Statutes; and Chapter 458, Florida Statutes.
At all times material to this complaint, Respondent was a
2.
licensed physician within the state of Florida, having been issued license
number ME 62450,
Sep 18 2009 14:21
Sep 18 2009 14:17 P. O04
‘wl!
w"
3. Respondent's address of record is 1010: Bucida Road, Delray
Beach, Florida 33483. |
4. On or about November 29, 2005, Patient J.S,, a forty-nine (49)
year old male, presented to Respondent complaining of back pain,
3. Respondent prescribed Oxycontin 40 mg every 12 hours (60
tablets) and Roxicodone 30 mg every 4 hours (150 tablets).
6. Oxycontin is a semi-synthetic opiate that contains oxycodone
hydrochloride, a Schedule II controlled substance defined in Chapter 893,
Florida Statutes, which is indicated for the relief of moderate to severe
pain. Oxycontin has a high potential for abuse and has a currently
accepted, but limited, medical use in treatment in the United States.
Abuse of this substance may lead to severe physical and psychological
dependence. ,
7. Roxicodone contains oxycodone hydrochloride.
8. Oxycodone hydrochloride, a semi-synthetic narcotic analgesic,
is a Schedule IT controlled substance under Chapter 893, Florida Statutes,
It is indicated for relief of moderate to moderately severe pain, It has a
high potential for abuse and has a currently accepted, but limited, medical
DOH v. Douglas R. Smith, M.D., Case No, 2006-28876 2
Sep 18 2009 14:21
Sep 18 2009 14:17 P.O5
‘el
wr’
use in treatment in the United States, and abuse of the substance may
lead to severe physical and psychological dependence.
9. On or about December 21, 2005, Respondent prescribed 80 mg
Oxycontin every 12 hours (60 tablets) and Roxicodone 30 mg every 4
hours (150 tablets) for 1.5, ,
10. On or about January 11, 2006, Respondent prescribed 80 mg
Oxycontin every 12 hours (60 tablets) and Roxicodone 30 mg. every 1-4
hours as needed (150 tablets) for 3.5.
11. On or about February 6, 2006, Respondent prescribed 80 mg
Oxycontin every 12 hours (60 tablets) for J.S.
12. On or about March 1, 2006, Respondent prescribed Roxicodone
30 mg every 4 hours (150 tablets) for 3.5.
13. On or about April 19, 2006, Respondent prescribed the
following medications for J.S.:
a Oxycontin 80 mg, 2 every 12 hours (120 tablets);
b. Roxicodone 30 mg 1-2 every 4 hours as needed (200
tablets); :
¢. a Duragesic patch (1 every 72 hours),
DOH v, Douglas R. Smith, M.D., Case No. 2006-28876 3
Sep 18 2009 14:22
Sep 18 2009 14:17 P. O06
wa
we
14. A Duragesic patch is applied to the skin so that the medication
it contains is slowly absorbed. 2
15. Duragesic patches contain Fentanyl, a Schedule IT controlled
substance under Chapter 893, Florida Statutes. Fentanyl is an opioid
indicated in the management of chronic pain in patients. It has a high
potential for abuse and has a currently accepted but severely restricted
medical use in treatment in the United States. Abuse of Fentanyl may lead
to severe physical and psychological dependence. |
16, Respondent's medical records for J.S. for April 19, 2006 do not
document justification for the addition of the Duragesic patch to ).S/
medication regimen. ,
17 On or about May 17, 2006, Respondent prescribed the
following medications for J.S.: |
a. Oxycontin 80 mg, 2 every 12 hours (120 tablets);
b. —_Roxicodone 30 mg 1-2 every 4 hours as needed (300
tablets); } i
¢. Duragesic patch 100 meg/hr, 1 patch every 2 days (15
patches).
DOH v. Douglas R. Smith, M.D.. Case No. 2006-28876 . 4
Sep 18 2009 14:22
Sep 18 2009 14:17 P.O?
wd
Ad
18. On or about June 13, 2006, Respondent prescribed the
following medications for J.S.:
a. Oxycontin 80 mg, 2 every 12 hours (120 tablets);
b. Roxicodone 30 mg, 1-2 every 4 hours as needed (100
tablets); i
Cc. Duragesic patch 100 mca/hr, 1 patch every 2 days (15
patches).
19. Respondent continued to prescribe the same combination of
medications as described above in paragraph 17 on July 11, 2006, August
8, 2006, September 6, 2006, October 5, 2006 and November 2, 2006.
20. Respondent did not conduct or did not document conducting a
physical examination of J.S. on August 8, 2006, September 6, 2006 or
October 5, 2006.
21. Respondent failed to coordinate his care of J.$. with 3.5, other
physicians, including his primary care physician.
22. Respondent failed to monitor J.S. with urine drug screens.
23. Respondent’s medical records for JS. do not document
justification for prescribing Oxycontin and Roxicodone simultaneously,
DOH v. Douglas R. Smith, M.D., Case No. 2006-28876 / 5
Sep 18 2009 14:22
Sep 18 2009 14:17 P. 08
st
‘wr’
24. Respondent's medical records for J3.$. do not. : document
justification for prescribing Oxycontin, Roxicodone and the Duragesc patch
simultaneously, |
25, Respondent's medical records for J.S. do not ‘document
justification for changes in medications or changes in dosages of the
medications.
COUNT ONE
26. Petitioner realleges and incorporates paragraphs one (1)
through twenty-five (25) as if fully set forth herein. ,
27. Section 458,331(1)(t), Florida Statutes (2005-2006) provides
that the failure to practice medicine with that level of care, ski, and
treatment which is recognized by a reasonably prudent similar physician as
being acceptable under similar conditions and circumstances is grounds for
disciplinary action by the Board of Medicine.
28. Rule 6488-9.013(3), Florida Administrative Code (FACY, which
is part of the chapter of the FAC where the Board of Medicine establishes
Standards of care for physicians, provides in relevant part:
6468-9.013 Standard for the Use of Controlled Substances
for the Treatment of Pain.
(1) Pain Management Principles.
DOH v, Douglas R. Smith, M.D., Case No. 2006-28876 : 6
Sep 18 2009 14:22
Sep 18 2009 14:18 P.09
ai"
~~’
(a) The Board of Medicine recognizes that principles of quality
medical practice dictate that the people of the State of Florida have
access to appropriate and effective pain relief. The appropriate
application of up-to-date knowledge and treatment modalities can
serve to improve the quality of life for those patients who suffer from
pain as well as reduce the morbidity and costs associated with
untreated or inappropriately treated pain. The Board e courages
physicians to view effective pain management as part of quality
medical practice for all patients with pain, acute or chronic, and it is
especially important for patients who experience pain as a result of
terminal illness. All physicians should become knowledgeable about
effective methods of pain treatment as well as _ statutory
requirements for prescribing controlled substances.
* * *
(c) The Board recognizes that controlled substances, including
opioid analgesics, may be essential in the treatment of acute
pain due to trauma or surgery and chronic pain, whether due
to cancer or non-cancer origins. The medical management of
pain including intractable pain should be based on current
knowledge and research and includes the use of both
pharmacologic and non-pharmacologic modalities, Pain should
be assessed and treated promptly, and the quantity and
frequency of doses should be adjusted according to the
intensity and duration of the pain. Physicians should recognize
that tolerance and physical dependence. are normal
consequences of sustained use of opioid analgesics and are not
synonymous with addiction.
(d) The Board of Medicine is obligated under the laws of the
State of Florida to protect the public health and safety. The
Board recognizes that inappropriate Prescribing of controlled
substances, including opioid analgesics, may. lead to drug
diversion and abuse by individuals who seek them for other
than legitimate medical use. Physicians should .be diligent in
preventing the diversion of drugs for illegitimate purposes,
(e) The Board will consider prescribing, ordering,
administering, or dispensing controlled substances for pain to
be for a legitimate medical purpose if based on accepted
DOH v, Douglas R. Smith, M.D., Case No, 2006-28876 : 7
Sep 18 2009 14:23
Sep 18 2009 14:18 P.10
Naw!
~~
scientific knowledge of the treatment of pain or if based on
sound clinical grounds. All such prescribing must be based on
clear documentation of unrelieved pain and in compliance with
applicable state or federal law.
(f) Each case of prescribing for pain will be evaluated on an
individual basis. The Board will not take disciplinary action
against a physician for failing to adhere strictly to the
provisions of these standards, if good cause is shown for such
deviation. The physician’s conduct will be evaluated to a great
extent by the treatment outcome, taking into account whether
the drug used is medically and/or pharmacologically recognized
to be appropriate for the diagnosis, the patient’s individual
needs including any improvement in functioning, and
recognizing that some types of pain cannot be completely
relieved,
(g) The Board will judge the validity of prescribing based on
the physician's treatment of the patient and on available
documentation, rather than on the quantity and chronicity of
prescribing. The goal is to control the patient’s pain for its
duration while effectively addressing other aspects of the
patient’s functioning, including physical, psychological, social,
and work-related factors. The following standards are not
intended to define complete or best practice, but rather to
communicate what the Board considers to be within 'the
boundaries of professional practice.
* * *
(3) Standards. The Board has adopted the following standards
for the use of controlled substances for pain control:
(a) Evaluation of the Patient. A complete medical history and
physical examination must be conducted and documented in
the medical record. The medical record should document the
nature and intensity of the pain, current and past treatments
for pain, underlying or coexisting diseases or conditions, the
effect of the pain on physical and psychological function, and
history of substance abuse. The medical record also should
DOH v. Douglas R. Smith, M.D., Case No. 2006-28876
Sep 18 2009 14:23
Sep 18 2009 14:18 PTT
~~
\w
document the presence of one or more recognized medical
Indications for the use of a controlled substance,
(b) Treatment Plan. The written treatment plan should state
objectives that will be used to determine treatment SUCCeSS,
such as pain relief and improved physical and psychosocial
function, and should indicate if any further diagnostic
evaluations or other treatments are planned. After treatment
begins, the physician should adjust drug therapy to the
individual medical needs of each patient. Other treatment
modalities or a rehabilitation program may be necessary
depending on the etiology of the pain and the ‘extent to which
the pain is associated with physical and psychosocial
impairment. :
(c) Informed Consent and Agreement for Treatment. The
Physician should discuss the risks and benefits of the use of
controlled substances with the patient, persons designated by
the patient, or with the patient’s Surrogate or guardian if the
patient is Incompetent, The patient should receive prescriptions
from one physician and one pharmacy where possible. If the
patient is determined to be at high risk for medication abuse or
have a history of substance abuse, the physician: should employ
the use of a written agreement between physician and patient
outlining patient responsibilities, including, but not limited to:
1, Urine/serum medication levels screening when requested;
2. Number and frequency of all prescription refills; and
3. Reasons for which drug therapy may be discontinued (i.e,
violation of agreement).
(d) Periodic Review. At reasonable intervals based on the
individual circumstances of the patient, the physician should
review the course of treatment and any new information about
the etiology of the pain. Continuation or modification | of
therapy should depend on the physician's evaluation of the
patient's progress. If treatment goals are not being achieved,
despite medication adjustments, the Physician should
reevaluate the appropriateness of continued treatment. The
physician should monitor patient compliance in medication
uSage and related treatment plans, :
DOH v. Douglas R. Smith, M.D., Case No, 20006-28876
Sep 18 2009 14:25
Sep 18 2009 14:19 PlL12
~~
‘ew
(e) Consultation. The physician should be willing to refer the
Patient as necessary for additional evaluation and treatment in
order to achieve treatment objectives. Special attention should
be given to those pain patients who are at risk for misusing
their medications and those whose living arrangements pose a
risk for medication misuse or diversion. The management of
pain in patients with a history of substance abuse or with a
comorbid psychiatric disorder requires extra care, monitoring,
and documentation, and may require’ consultation with or
referral to an expert in the management of such patients. —
(f) Medical Records. The physician is required to keep accurate
and complete records to include, but not be limited to:
1. The medical history and physical examination, including
history of drug abuse or dependence, as appropriate;
2. Diagnostic, therapeutic, and laboratory results; :
3. Evaluations and consultations; .
4. Treatment objectives;
5. Discussion of risks and benefits;
6. Treatments;
7, Medications (including date, type, dosage, and quantity
prescribed);
8. Instructions and agreements; and
9. Periodic reviews.
Records must remain current and be maintained in: an
accessible manner and readily available for review.
(9) Compliance with Controlled Substances Laws and
Regulations, To prescribe, dispense, or administer controlled
Substances, the physician must be licensed in the state and
comply with applicable federal and state regulations, Physicians
are referred to the Physicians Manual: An Informational Outline
of the Controlled Substances Act of 1970, published by the U.S.
Drug Enforcement Agency, for specific rules governing
controlled substances as well as applicable state. regulations.
29. Respondent failed to practice medicine with that level of care,
skill, and treatment which is recognized by a reasonably prudent similar
DOH v. Douglas R. Smith, M.D., Case No. 2006-28876 10
Sep 18 2009 14:24
Sep 18 2009 14:19 P.13
al!
‘oe
physician as being acceptable under similar conditions and circumstances
in one or more of the following ways: |
a. By prescribing Oxycontin and Duragesic patch
simultaneously for J.S. without justification; |
b. By __ prescribing Oxycontin, Duragesic patch and
Roxicodone simultaneously for patient J.S. without Justification;
Cc. By failing to comply with Rule 64B8-9.013(3)(a), Florida
Administrative Code, which provides that a complete medical history
and physical examination must be conducted and documented in the
medical record. 3
30. Based on the foregoing, Respondent has violated Section
458.331(1)(t), Florida Statutes (2005-2006), by failing to practice medicine
with that level of care, skill, and treatment which. is recognized by a
reasonably prudent similar physician as being acceptable under similar
conditions and circurnstances. :
COUNT TWO
31. Petitioner realleges and incorporates paragraphs ione (1)
through twenty-five (25) as if fully set forth in this count.
DOH v. Douglas R, Smith, M.D,, Case No, 2006-28876 : It
Sep 18 2009 14:24
Sep 18 2009 14:19 P14
wel
Sol
32. Section 458,331(1)(q), Florida Statutes (2005-2006), provides
that prescribing, dispensing, administering, mixing, or otherwise preparing
a legend drug, including any controlled substance, other than in the course
of the physician's professional practice constitutes grounds for disciplinary
action by the Board of Medicine. For the purposes of this paragraph, it
shall be legally presumed that prescribing, dispensing, administering,
mixing, Or otherwise preparing legend drugs, including all controlled
substances, inappropriately or in excessive or inappropriate quantities is
not in the best interest of the patient and is not in the course of the
physician's professional practice, without regard to his or her Intent.
33. Respondent inappropriately prescribed controlled substances to
J.S, other than in the course of his Professional practice by prescribing
without any documented justification for the medications, changes in
medications or changes in dosages of the medications.
34. Based on the foregoing, Respondent has violated Section
458.331(1)(q), Florida Statutes (2005-2006), by Prescribing, dispensing,
administering, mixing, or otherwise preparing a legend drug, including any
controlled substance, other than in the course of the physician's
professional practice, For the purposes of this paragraph, it shail be ® legally
DOH v. Douglas R. Sinith, M.D., Case No. 2006-288 76
Sep 18 2009 14:24
Sep 18 2009 14:20 P.15
wel
od
presumed that prescribing, dispensing, administering, mixing, or otherwise
Preparing legend drugs, including all controlled substances, inappropriately
or in excessive or inappropriate quantities is not in the best interest of the
patient and is not in the course of the physician's: professional Practice,
, without regard to his or her intent,
COUNT THREE |
35. Petitioner realleges and incorporates Paragraphs one (1)
through twenty-five (25) as if fully set forth in this count.
36. Section 458.331( iX(m), Florida Statutes (2005- 2006), Provides
that failing to keep legible, as defined by department rule in consultation
with the board, medical records that identify the licensed physician or the
physician extender and Supervising physician by name and professional
title who is or are responsible for rendering, ordering, . supervising, or
billing for each diagnostic or treatment procedure and that justi the
course of treatment of the patient, including, but not limited t, patient
histories; examination results; test results; records of drugs prescribed,
dispensed, or administered; and reports of consultations and
hospitalizations constitutes grounds for disciplinary action by the Board of
Medicine.
DOH v. Douglas R. Smith, M.D., Case No. 2006-28876 . 3
Sep 18 2009 14:24
Sep 18 2009 14:20 P.16
Nepe’
37. Respondent failed to keep medical records that justity the
course of treatment of J.S. in one or more of the following ways: !
a. By failing to document the justification for prescribing
Oxycontin and Duragesic patch in the dosages and
circumstances that he did; :
b. By failing to document the justification for prescribing
Oxycontin, Duragesic patch and Roxicodone in the
dosages and circumstances that he did; |
c. By failing to document a complete medical history or
complete physical examination. |
38. Based on the foregoing, Respondent has violated Section
458.331(1)(m), Florida Statutes (2005-2006), by failing to keep medical
records that justify the course of treatment of the patient, including, but
not limited to, patient histories; examination results; test results; records
of drugs prescribed, dispensed, or administered; and reports of
consultations and hospitalizations. !
WHEREFORE, the Petitioner respectfully requests that the Board of
Medicine enter an order imposing one or more of the following penalties:
permanent revocation or suspension of Respondent's license, restriction of
DOH v. Douglas R. Smith, M.D., Case No, 2006-28876 14
Sep 18 2009 14:25
Sep 18 2009 14:20 PL?
we ‘we!
practice, imposition of an administrative fine, issuance of a reprimand,
placement of the Respondent on probation, corrective action, refund of
fees billed or collected, remedial education and/or any other relief that the
Board deems appropriate.
SIGNED this 3°" dayof_ /77e-<4 2008.
Ana M. Viamonte Ros, M, D, M.PH.
State Surgeon General
sistant General Counsel
DOH-Prosecution eWeek Unit
4052 Bald Cypress Way-Bin C-65
1-7 Tallahassee, Florida 32399-3265
Florida Bar #0544825
(850) 245-4640
(850) 245-4680 fax
PCP: February 29, 2008
Panel: Dr. El-Bahri, Dr, Davies, Ms. Long
DOH v. Dougias R. Smith, M.D., Case No. 2006-28876 15
Sep 18 2009 14:25
Sep 18 2009 14:20 P.18
NOTICE OF RIGHTS
Respondent has the right to request a hearing to be
conducted in accordance with Section 120.569 and 120.57,
Florida Statutes, to be represented by counsel or other qualified
representative, to present evidence and argument, to call and
cross-examine witnesses and to have subpoena and’ subpoena
duces tecum issued on his or her behalf if a hearing is requested,
NOTICE REGARDING ASSESSMENT OF COSTS |
Respondent is placed on notice that Petitioner has' incurred
costs related to the investigation and proseaition of this matter.
Pursuant to Section 456.072(4), Florida Statutes, the soar shall
assess costs related to the investigation and prosecution of a
disciplinary matter, which may include attorney hours and costs,
on the Respondent in addition to any other discipline imposed.
DOH v. Dougias R. Smith, M.D., Case No. 2006-28876 . : 16
Docket for Case No: 09-005176PL
Issue Date |
Proceedings |
Nov. 04, 2009 |
Order Closing File. CASE CLOSED.
|
Oct. 27, 2009 |
Joint Motion for Continuance filed.
|
Oct. 23, 2009 |
Joint Pre-hearing Stipulation filed.
|
Oct. 22, 2009 |
Notice of Taking Deposition (of M. Gerber) filed.
|
Oct. 13, 2009 |
Amended Administrative Complaint filed.
|
Oct. 13, 2009 |
Order Granting Motion to Amend Administrative Complaint
|
Oct. 13, 2009 |
Unopposed Motion for Leave to Amend Administrative Complaint filed.
|
Oct. 07, 2009 |
Notice of Serving Petitioner's First Request for Production, First Set of Interrogatories, and First Request for Admissions to Respondent filed.
|
Oct. 02, 2009 |
Notice of Appearance (of J. Ingle) filed.
|
Oct. 01, 2009 |
Notice of Appearance as Co-counsel (of D. Kiesling) filed.
|
Sep. 30, 2009 |
Order of Pre-hearing Instructions.
|
Sep. 30, 2009 |
Notice of Hearing (hearing set for November 12 and 13, 2009; 9:30 a.m.; West Palm Beach, FL).
|
Sep. 28, 2009 |
Joint Response to Initial Order filed.
|
Sep. 21, 2009 |
Initial Order.
|
Sep. 18, 2009 |
Election of Rights filed.
|
Sep. 18, 2009 |
Administrative Complaint filed.
|
Sep. 18, 2009 |
Agency referral filed.
|
Sep. 18, 2009 |
Notice of Appearance (filed by D. Pius).
|